Literature DB >> 17722032

Distribution of the voltage-gated sodium channel Na(v)1.7 in the rat: expression in the autonomic and endocrine systems.

Anne Morinville1, Bengt Fundin, Luc Meury, Anders Juréus, Kristian Sandberg, Johannes Krupp, Sultan Ahmad, Dajan O'Donnell.   

Abstract

It is generally accepted that the voltage-gated, tetrodotoxin-sensitive sodium channel, Na(V)1.7, is selectively expressed in peripheral ganglia. However, global deletion in mice of Na(V)1.7 leads to death shortly after birth (Nassar et al. [2004] Proc. Natl. Acad. Sci. U. S. A. 101:12706-12711), suggesting that this ion channel might be more widely expressed. To understand better the potential physiological function of this ion channel, we examined Na(V)1.7 expression in the rat by in situ hybridization and immunohistochemistry. As expected, highest mRNA expression levels are found in peripheral ganglia, and the protein is expressed within these ganglion cells and on the projections of these neurons in the central nervous system. Importantly, we found that Na(V)1.7 is present in discrete rat brain regions, and the unique distribution pattern implies a central involvement in endocrine and autonomic systems as well as analgesia. In addition, Na(V)1.7 expression was detected in the pituitary and adrenal glands. These results indicate that Na(V)1.7 is not only involved in the processing of sensory information but also participates in the regulation of autonomic and endocrine systems; more specifically, it could be implicated in such vital functions as fluid homeostasis and cardiovascular control.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17722032     DOI: 10.1002/cne.21484

Source DB:  PubMed          Journal:  J Comp Neurol        ISSN: 0021-9967            Impact factor:   3.215


  20 in total

Review 1.  Ion channels and signaling in the pituitary gland.

Authors:  Stanko S Stojilkovic; Joël Tabak; Richard Bertram
Journal:  Endocr Rev       Date:  2010-07-21       Impact factor: 19.871

2.  Actions of KMUP-1, a xanthine and piperazine derivative, on voltage-gated Na(+) and Ca(2+) -activated K(+) currents in GH3 pituitary tumour cells.

Authors:  Yi-Ching Lo; Yu-Ting Tseng; Chi-Ming Liu; Bin-Nan Wu; Sheng-Nan Wu
Journal:  Br J Pharmacol       Date:  2015-10-25       Impact factor: 8.739

3.  A case of primary erythermalgia with encephalopathy.

Authors:  Julien Seneschal; Guilhem Solé; Alain Taieb; Xavier Ferrer
Journal:  J Neurol       Date:  2009-06-17       Impact factor: 4.849

4.  Safety, Tolerability, and Pharmacokinetics of GDC-0276, a Novel NaV1.7 Inhibitor, in a First-in-Human, Single- and Multiple-Dose Study in Healthy Volunteers.

Authors:  Michael E Rothenberg; Michael Tagen; Jae H Chang; Janel Boyce-Rustay; Michel Friesenhahn; David H Hackos; Avis Hains; Dan Sutherlin; Michael Ward; William Cho
Journal:  Clin Drug Investig       Date:  2019-09       Impact factor: 2.859

5.  Discovery and hit-to-lead evaluation of piperazine amides as selective, state-dependent NaV1.7 inhibitors.

Authors:  Brian A Sparling; S Yi; J Able; H Bregman; Erin F DiMauro; R S Foti; H Gao; A Guzman-Perez; H Huang; M Jarosh; T Kornecook; J Ligutti; B C Milgram; B D Moyer; B Youngblood; V L Yu; M M Weiss
Journal:  Medchemcomm       Date:  2016-12-02       Impact factor: 3.597

6.  Reduced availability of voltage-gated sodium channels by depolarization or blockade by tetrodotoxin boosts burst firing and catecholamine release in mouse chromaffin cells.

Authors:  David H F Vandael; Matteo M Ottaviani; Christian Legros; Claudie Lefort; Nathalie C Guérineau; Arianna Allio; Valentina Carabelli; Emilio Carbone
Journal:  J Physiol       Date:  2015-01-26       Impact factor: 5.182

Review 7.  Voltage-gated sodium channels: (NaV )igating the field to determine their contribution to visceral nociception.

Authors:  Andelain Erickson; Annemie Deiteren; Andrea M Harrington; Sonia Garcia-Caraballo; Joel Castro; Ashlee Caldwell; Luke Grundy; Stuart M Brierley
Journal:  J Physiol       Date:  2018-02-06       Impact factor: 5.182

Review 8.  Dependence of the excitability of pituitary cells on cyclic nucleotides.

Authors:  S S Stojilkovic; K Kretschmannova; M Tomić; C A Stratakis
Journal:  J Neuroendocrinol       Date:  2012-09       Impact factor: 3.627

9.  Insensitivity to Pain upon Adult-Onset Deletion of Nav1.7 or Its Blockade with Selective Inhibitors.

Authors:  Shannon D Shields; Lunbin Deng; Rebecca M Reese; Michelle Dourado; Janet Tao; Oded Foreman; Jae H Chang; David H Hackos
Journal:  J Neurosci       Date:  2018-10-09       Impact factor: 6.167

10.  Loss-of-function mutations in sodium channel Nav1.7 cause anosmia.

Authors:  Jan Weiss; Martina Pyrski; Eric Jacobi; Bernd Bufe; Vivienne Willnecker; Bernhard Schick; Philippe Zizzari; Samuel J Gossage; Charles A Greer; Trese Leinders-Zufall; C Geoffrey Woods; John N Wood; Frank Zufall
Journal:  Nature       Date:  2011-03-23       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.